As many as 65 children in Uzbekistan died after being given the Indian cough and cold syrup "Doc-1 Max", a representative of the Uzbek Supreme Court said on August 11. Officials in the country have previously only referred to around 20 victims.
A criminal case centred on the deaths caused by the contaminated medicine began on August 11 in Uzbekistan. The court heard that 21 people, all Uzbek citizens apart from one citizen of India, who is the director of Quramax Medikal, were being held in the case.
Charges pressed include tax evasion, the production, manufacture, acquisition, storage, transportation for sale or sale of substandard or falsified medicines or medical products, abuse of office, negligence, forgery and bribery.
In December 2022, the cough syrup Doc-1 Max, produced by Indian company Marion Biotech, was associated with the deaths of at least 20 children in Uzbekistan.
The Indian regulator later cancelled the manufacturing licence of Marion Biotech, which exported the medicines to Uzbekistan, and arrested some of its employees.
Don’t just follow the news—understand it.
The IntelliNews PRO service includes access to reports, exclusive market data, and more news that decision-makers care about. Stay ahead of the market with IntelliNews PRO.
Sign Up NowRelated Articles
India bars JPMorgan unit over Sensex closing auction manipulation
India's market regulator has barred a Mauritius-registered arm of JPMorgan Chase from the country's capital markets, accusing it of rigging the closing price of the Sensex on options expiry day, it ... more
India's banks scale record profits as bad loans sink to 1.8%
India's banks are earning more than ever and carrying the fewest bad loans in decades, just as falling interest rates begin to squeeze the margins behind the boom. That combination of peak ... more
India's ICICI Bank raises $750mn in five-year dollar bond
India’s ICICI Bank (NSE: ICICIBANK) has raised $750mn through a five-year US dollar bond at a spread tighter than its initial guidance, extending a recent surge in offshore fundraising by Indian ... more